Atlas One · Host Biology · Scale 07 — System

Esophageal Cancer

Esophageal cancer includes ESCC (squamous, smoking/alcohol) and EAC (adenocarcinoma, Barrett's/HER2+ ~15%); nivolumab+chemotherapy (CheckMate 648) is first-line for ESCC; trastuzumab+chemotherapy (ToGA) and T-DXd for HER2+ EAC; 5-year OS ~20%.

Also known as: esophageal cancer, ESCC, esophageal squamous cell carcinoma, EAC, esophageal adenocarcinoma, Barrett's esophagus cancer, GEJ cancer, gastroesophageal junction cancer, CheckMate 648, ATTRACTION-3

Scale 07 — SystemScale
draftStatus
2026-06-06Last Reviewed
This is an auto-generated stub page built from atlas entry frontmatter. A richer hand-crafted page is planned. See the atlas source for the full entry including detailed body sections.
esophageal-cancer

Esophageal Cancer

Esophageal cancer includes ESCC (squamous, smoking/alcohol) and EAC (adenocarcinoma, Barrett's/HER2+ ~15%); nivolumab+chemotherapy (CheckMate 648) is first-line for ESCC; trastuzumab+chemotherapy (ToGA) and T-DXd for HER2+ EAC; 5-year OS ~20%.